Global Phosphodiesterase-4 Inhibitor Market Growth 2026-2032

April 2026 | 92 pages | ID: G761490DB60DEN
LP Information

Abstracts

The global Phosphodiesterase-4 Inhibitor market size is predicted to grow from US$ 194 million in 2025 to US$ 304 million in 2032; it is expected to grow at a CAGR of 6.7% from 2026 to 2032.

United States market for Phosphodiesterase-4 Inhibitor is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Phosphodiesterase-4 Inhibitor is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Phosphodiesterase-4 Inhibitor is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Phosphodiesterase-4 Inhibitor players cover Camber Pharmaceuticals, AstraZeneca, GSK, Arcutis Biotherapeutics, Amgen, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LP Information, Inc. (LPI) ' newest research report, the ?Phosphodiesterase-4 Inhibitor Industry Forecast? looks at past sales and reviews total world Phosphodiesterase-4 Inhibitor sales in 2025, providing a comprehensive analysis by region and market sector of projected Phosphodiesterase-4 Inhibitor sales for 2026 through 2032. With Phosphodiesterase-4 Inhibitor sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Phosphodiesterase-4 Inhibitor industry.

This Insight Report provides a comprehensive analysis of the global Phosphodiesterase-4 Inhibitor landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Phosphodiesterase-4 Inhibitor portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Phosphodiesterase-4 Inhibitor market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Phosphodiesterase-4 Inhibitor and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Phosphodiesterase-4 Inhibitor.

This report presents a comprehensive overview, market shares, and growth opportunities of Phosphodiesterase-4 Inhibitor market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Oral
• External Use

Segmentation by Application:

• Children
• Adults

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Camber Pharmaceuticals
• AstraZeneca
• GSK
• Arcutis Biotherapeutics
• Amgen
• Fosun-Pharmaceutical

Key Questions Addressed in this Report

• What is the 10-year outlook for the global Phosphodiesterase-4 Inhibitor market?
• What factors are driving Phosphodiesterase-4 Inhibitor market growth, globally and by region?
• Which technologies are poised for the fastest growth by market and region?
• How do Phosphodiesterase-4 Inhibitor market opportunities vary by end market size?
• How does Phosphodiesterase-4 Inhibitor break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Phosphodiesterase-4 Inhibitor Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Phosphodiesterase-4 Inhibitor by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Phosphodiesterase-4 Inhibitor by Country/Region, 2021, 2025 & 2032
2.2 Phosphodiesterase-4 Inhibitor Segment by Type
  2.2.1 Oral
  2.2.2 External Use
  2.2.3 Phosphodiesterase-4 Inhibitor Sales by Type
    2.2.3.1 Global Phosphodiesterase-4 Inhibitor Sales Market Share by Type (2021-2026)
    2.2.3.2 Global Phosphodiesterase-4 Inhibitor Revenue and Market Share by Type (2021-2026)
    2.2.3.3 Global Phosphodiesterase-4 Inhibitor Sale Price by Type (2021-2026)
2.3 Phosphodiesterase-4 Inhibitor Segment by Application
  2.3.1 Children
  2.3.2 Adults
  2.3.3 Phosphodiesterase-4 Inhibitor Sales by Application
    2.3.3.1 Global Phosphodiesterase-4 Inhibitor Sale Market Share by Application (2021-2026)
    2.3.3.2 Global Phosphodiesterase-4 Inhibitor Revenue and Market Share by Application (2021-2026)
    2.3.3.3 Global Phosphodiesterase-4 Inhibitor Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global Phosphodiesterase-4 Inhibitor Breakdown Data by Company
  3.1.1 Global Phosphodiesterase-4 Inhibitor Annual Sales by Company (2021-2026)
  3.1.2 Global Phosphodiesterase-4 Inhibitor Sales Market Share by Company (2021-2026)
3.2 Global Phosphodiesterase-4 Inhibitor Annual Revenue by Company (2021-2026)
  3.2.1 Global Phosphodiesterase-4 Inhibitor Revenue by Company (2021-2026)
  3.2.2 Global Phosphodiesterase-4 Inhibitor Revenue Market Share by Company (2021-2026)
3.3 Global Phosphodiesterase-4 Inhibitor Sale Price by Company
3.4 Key Manufacturers Phosphodiesterase-4 Inhibitor Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Phosphodiesterase-4 Inhibitor Product Location Distribution
  3.4.2 Players Phosphodiesterase-4 Inhibitor Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR PHOSPHODIESTERASE-4 INHIBITOR BY GEOGRAPHIC REGION

4.1 World Historic Phosphodiesterase-4 Inhibitor Market Size by Geographic Region (2021-2026)
  4.1.1 Global Phosphodiesterase-4 Inhibitor Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Phosphodiesterase-4 Inhibitor Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Phosphodiesterase-4 Inhibitor Market Size by Country/Region (2021-2026)
  4.2.1 Global Phosphodiesterase-4 Inhibitor Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Phosphodiesterase-4 Inhibitor Annual Revenue by Country/Region (2021-2026)
4.3 Americas Phosphodiesterase-4 Inhibitor Sales Growth
4.4 APAC Phosphodiesterase-4 Inhibitor Sales Growth
4.5 Europe Phosphodiesterase-4 Inhibitor Sales Growth
4.6 Middle East & Africa Phosphodiesterase-4 Inhibitor Sales Growth

5 AMERICAS

5.1 Americas Phosphodiesterase-4 Inhibitor Sales by Country
  5.1.1 Americas Phosphodiesterase-4 Inhibitor Sales by Country (2021-2026)
  5.1.2 Americas Phosphodiesterase-4 Inhibitor Revenue by Country (2021-2026)
5.2 Americas Phosphodiesterase-4 Inhibitor Sales by Type (2021-2026)
5.3 Americas Phosphodiesterase-4 Inhibitor Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Phosphodiesterase-4 Inhibitor Sales by Region
  6.1.1 APAC Phosphodiesterase-4 Inhibitor Sales by Region (2021-2026)
  6.1.2 APAC Phosphodiesterase-4 Inhibitor Revenue by Region (2021-2026)
6.2 APAC Phosphodiesterase-4 Inhibitor Sales by Type (2021-2026)
6.3 APAC Phosphodiesterase-4 Inhibitor Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Phosphodiesterase-4 Inhibitor by Country
  7.1.1 Europe Phosphodiesterase-4 Inhibitor Sales by Country (2021-2026)
  7.1.2 Europe Phosphodiesterase-4 Inhibitor Revenue by Country (2021-2026)
7.2 Europe Phosphodiesterase-4 Inhibitor Sales by Type (2021-2026)
7.3 Europe Phosphodiesterase-4 Inhibitor Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Phosphodiesterase-4 Inhibitor by Country
  8.1.1 Middle East & Africa Phosphodiesterase-4 Inhibitor Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Phosphodiesterase-4 Inhibitor Revenue by Country (2021-2026)
8.2 Middle East & Africa Phosphodiesterase-4 Inhibitor Sales by Type (2021-2026)
8.3 Middle East & Africa Phosphodiesterase-4 Inhibitor Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Phosphodiesterase-4 Inhibitor
10.3 Manufacturing Process Analysis of Phosphodiesterase-4 Inhibitor
10.4 Industry Chain Structure of Phosphodiesterase-4 Inhibitor

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Phosphodiesterase-4 Inhibitor Distributors
11.3 Phosphodiesterase-4 Inhibitor Customer

12 WORLD FORECAST REVIEW FOR PHOSPHODIESTERASE-4 INHIBITOR BY GEOGRAPHIC REGION

12.1 Global Phosphodiesterase-4 Inhibitor Market Size Forecast by Region
  12.1.1 Global Phosphodiesterase-4 Inhibitor Forecast by Region (2027-2032)
  12.1.2 Global Phosphodiesterase-4 Inhibitor Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Phosphodiesterase-4 Inhibitor Forecast by Type (2027-2032)
12.7 Global Phosphodiesterase-4 Inhibitor Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 Camber Pharmaceuticals
  13.1.1 Camber Pharmaceuticals Company Information
  13.1.2 Camber Pharmaceuticals Phosphodiesterase-4 Inhibitor Product Portfolios and Specifications
  13.1.3 Camber Pharmaceuticals Phosphodiesterase-4 Inhibitor Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Camber Pharmaceuticals Main Business Overview
  13.1.5 Camber Pharmaceuticals Latest Developments
13.2 AstraZeneca
  13.2.1 AstraZeneca Company Information
  13.2.2 AstraZeneca Phosphodiesterase-4 Inhibitor Product Portfolios and Specifications
  13.2.3 AstraZeneca Phosphodiesterase-4 Inhibitor Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 AstraZeneca Main Business Overview
  13.2.5 AstraZeneca Latest Developments
13.3 GSK
  13.3.1 GSK Company Information
  13.3.2 GSK Phosphodiesterase-4 Inhibitor Product Portfolios and Specifications
  13.3.3 GSK Phosphodiesterase-4 Inhibitor Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 GSK Main Business Overview
  13.3.5 GSK Latest Developments
13.4 Arcutis Biotherapeutics
  13.4.1 Arcutis Biotherapeutics Company Information
  13.4.2 Arcutis Biotherapeutics Phosphodiesterase-4 Inhibitor Product Portfolios and Specifications
  13.4.3 Arcutis Biotherapeutics Phosphodiesterase-4 Inhibitor Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 Arcutis Biotherapeutics Main Business Overview
  13.4.5 Arcutis Biotherapeutics Latest Developments
13.5 Amgen
  13.5.1 Amgen Company Information
  13.5.2 Amgen Phosphodiesterase-4 Inhibitor Product Portfolios and Specifications
  13.5.3 Amgen Phosphodiesterase-4 Inhibitor Sales, Revenue, Price and Gross Margin (2021-2026)
  13.5.4 Amgen Main Business Overview
  13.5.5 Amgen Latest Developments
13.6 Fosun-Pharmaceutical
  13.6.1 Fosun-Pharmaceutical Company Information
  13.6.2 Fosun-Pharmaceutical Phosphodiesterase-4 Inhibitor Product Portfolios and Specifications
  13.6.3 Fosun-Pharmaceutical Phosphodiesterase-4 Inhibitor Sales, Revenue, Price and Gross Margin (2021-2026)
  13.6.4 Fosun-Pharmaceutical Main Business Overview
  13.6.5 Fosun-Pharmaceutical Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Phosphodiesterase-4 Inhibitor Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Phosphodiesterase-4 Inhibitor Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Oral
Table 4. Major Players of External Use
Table 5. Global Phosphodiesterase-4 Inhibitor Sales by Type (2021-2026) & (K Units)
Table 6. Global Phosphodiesterase-4 Inhibitor Sales Market Share by Type (2021-2026)
Table 7. Global Phosphodiesterase-4 Inhibitor Revenue by Type (2021-2026) & ($ million)
Table 8. Global Phosphodiesterase-4 Inhibitor Revenue Market Share by Type (2021-2026)
Table 9. Global Phosphodiesterase-4 Inhibitor Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Phosphodiesterase-4 Inhibitor Sale by Application (2021-2026) & (K Units)
Table 11. Global Phosphodiesterase-4 Inhibitor Sale Market Share by Application (2021-2026)
Table 12. Global Phosphodiesterase-4 Inhibitor Revenue by Application (2021-2026) & ($ million)
Table 13. Global Phosphodiesterase-4 Inhibitor Revenue Market Share by Application (2021-2026)
Table 14. Global Phosphodiesterase-4 Inhibitor Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Phosphodiesterase-4 Inhibitor Sales by Company (2021-2026) & (K Units)
Table 16. Global Phosphodiesterase-4 Inhibitor Sales Market Share by Company (2021-2026)
Table 17. Global Phosphodiesterase-4 Inhibitor Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Phosphodiesterase-4 Inhibitor Revenue Market Share by Company (2021-2026)
Table 19. Global Phosphodiesterase-4 Inhibitor Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Phosphodiesterase-4 Inhibitor Producing Area Distribution and Sales Area
Table 21. Players Phosphodiesterase-4 Inhibitor Products Offered
Table 22. Phosphodiesterase-4 Inhibitor Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Phosphodiesterase-4 Inhibitor Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Phosphodiesterase-4 Inhibitor Sales Market Share Geographic Region (2021-2026)
Table 27. Global Phosphodiesterase-4 Inhibitor Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Phosphodiesterase-4 Inhibitor Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Phosphodiesterase-4 Inhibitor Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Phosphodiesterase-4 Inhibitor Sales Market Share by Country/Region (2021-2026)
Table 31. Global Phosphodiesterase-4 Inhibitor Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Phosphodiesterase-4 Inhibitor Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Phosphodiesterase-4 Inhibitor Sales by Country (2021-2026) & (K Units)
Table 34. Americas Phosphodiesterase-4 Inhibitor Sales Market Share by Country (2021-2026)
Table 35. Americas Phosphodiesterase-4 Inhibitor Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Phosphodiesterase-4 Inhibitor Sales by Type (2021-2026) & (K Units)
Table 37. Americas Phosphodiesterase-4 Inhibitor Sales by Application (2021-2026) & (K Units)
Table 38. APAC Phosphodiesterase-4 Inhibitor Sales by Region (2021-2026) & (K Units)
Table 39. APAC Phosphodiesterase-4 Inhibitor Sales Market Share by Region (2021-2026)
Table 40. APAC Phosphodiesterase-4 Inhibitor Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Phosphodiesterase-4 Inhibitor Sales by Type (2021-2026) & (K Units)
Table 42. APAC Phosphodiesterase-4 Inhibitor Sales by Application (2021-2026) & (K Units)
Table 43. Europe Phosphodiesterase-4 Inhibitor Sales by Country (2021-2026) & (K Units)
Table 44. Europe Phosphodiesterase-4 Inhibitor Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Phosphodiesterase-4 Inhibitor Sales by Type (2021-2026) & (K Units)
Table 46. Europe Phosphodiesterase-4 Inhibitor Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Phosphodiesterase-4 Inhibitor Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Phosphodiesterase-4 Inhibitor Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Phosphodiesterase-4 Inhibitor Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Phosphodiesterase-4 Inhibitor Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Phosphodiesterase-4 Inhibitor
Table 52. Key Market Challenges & Risks of Phosphodiesterase-4 Inhibitor
Table 53. Key Industry Trends of Phosphodiesterase-4 Inhibitor
Table 54. Phosphodiesterase-4 Inhibitor Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Phosphodiesterase-4 Inhibitor Distributors List
Table 57. Phosphodiesterase-4 Inhibitor Customer List
Table 58. Global Phosphodiesterase-4 Inhibitor Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Phosphodiesterase-4 Inhibitor Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Phosphodiesterase-4 Inhibitor Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Phosphodiesterase-4 Inhibitor Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Phosphodiesterase-4 Inhibitor Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Phosphodiesterase-4 Inhibitor Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Phosphodiesterase-4 Inhibitor Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Phosphodiesterase-4 Inhibitor Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Phosphodiesterase-4 Inhibitor Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Phosphodiesterase-4 Inhibitor Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Phosphodiesterase-4 Inhibitor Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Phosphodiesterase-4 Inhibitor Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Phosphodiesterase-4 Inhibitor Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Phosphodiesterase-4 Inhibitor Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Camber Pharmaceuticals Basic Information, Phosphodiesterase-4 Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 73. Camber Pharmaceuticals Phosphodiesterase-4 Inhibitor Product Portfolios and Specifications
Table 74. Camber Pharmaceuticals Phosphodiesterase-4 Inhibitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Camber Pharmaceuticals Main Business
Table 76. Camber Pharmaceuticals Latest Developments
Table 77. AstraZeneca Basic Information, Phosphodiesterase-4 Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 78. AstraZeneca Phosphodiesterase-4 Inhibitor Product Portfolios and Specifications
Table 79. AstraZeneca Phosphodiesterase-4 Inhibitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. AstraZeneca Main Business
Table 81. AstraZeneca Latest Developments
Table 82. GSK Basic Information, Phosphodiesterase-4 Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 83. GSK Phosphodiesterase-4 Inhibitor Product Portfolios and Specifications
Table 84. GSK Phosphodiesterase-4 Inhibitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. GSK Main Business
Table 86. GSK Latest Developments
Table 87. Arcutis Biotherapeutics Basic Information, Phosphodiesterase-4 Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 88. Arcutis Biotherapeutics Phosphodiesterase-4 Inhibitor Product Portfolios and Specifications
Table 89. Arcutis Biotherapeutics Phosphodiesterase-4 Inhibitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Arcutis Biotherapeutics Main Business
Table 91. Arcutis Biotherapeutics Latest Developments
Table 92. Amgen Basic Information, Phosphodiesterase-4 Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 93. Amgen Phosphodiesterase-4 Inhibitor Product Portfolios and Specifications
Table 94. Amgen Phosphodiesterase-4 Inhibitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Amgen Main Business
Table 96. Amgen Latest Developments
Table 97. Fosun-Pharmaceutical Basic Information, Phosphodiesterase-4 Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 98. Fosun-Pharmaceutical Phosphodiesterase-4 Inhibitor Product Portfolios and Specifications
Table 99. Fosun-Pharmaceutical Phosphodiesterase-4 Inhibitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Fosun-Pharmaceutical Main Business
Table 101. Fosun-Pharmaceutical Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Phosphodiesterase-4 Inhibitor
Figure 2. Phosphodiesterase-4 Inhibitor Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Phosphodiesterase-4 Inhibitor Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Phosphodiesterase-4 Inhibitor Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Phosphodiesterase-4 Inhibitor Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Phosphodiesterase-4 Inhibitor Sales Market Share by Country/Region (2025)
Figure 10. Phosphodiesterase-4 Inhibitor Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Oral
Figure 12. Product Picture of External Use
Figure 13. Global Phosphodiesterase-4 Inhibitor Sales Market Share by Type in 2026
Figure 14. Global Phosphodiesterase-4 Inhibitor Revenue Market Share by Type (2021-2026)
Figure 15. Phosphodiesterase-4 Inhibitor Consumed in Children
Figure 16. Global Phosphodiesterase-4 Inhibitor Market: Children (2021-2026) & (K Units)
Figure 17. Phosphodiesterase-4 Inhibitor Consumed in Adults
Figure 18. Global Phosphodiesterase-4 Inhibitor Market: Adults (2021-2026) & (K Units)
Figure 19. Global Phosphodiesterase-4 Inhibitor Sale Market Share by Application (2025)
Figure 20. Global Phosphodiesterase-4 Inhibitor Revenue Market Share by Application in 2026
Figure 21. Phosphodiesterase-4 Inhibitor Sales by Company in 2026 (K Units)
Figure 22. Global Phosphodiesterase-4 Inhibitor Sales Market Share by Company in 2026
Figure 23. Phosphodiesterase-4 Inhibitor Revenue by Company in 2026 ($ millions)
Figure 24. Global Phosphodiesterase-4 Inhibitor Revenue Market Share by Company in 2026
Figure 25. Global Phosphodiesterase-4 Inhibitor Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Phosphodiesterase-4 Inhibitor Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Phosphodiesterase-4 Inhibitor Sales 2021-2026 (K Units)
Figure 28. Americas Phosphodiesterase-4 Inhibitor Revenue 2021-2026 ($ millions)
Figure 29. APAC Phosphodiesterase-4 Inhibitor Sales 2021-2026 (K Units)
Figure 30. APAC Phosphodiesterase-4 Inhibitor Revenue 2021-2026 ($ millions)
Figure 31. Europe Phosphodiesterase-4 Inhibitor Sales 2021-2026 (K Units)
Figure 32. Europe Phosphodiesterase-4 Inhibitor Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Phosphodiesterase-4 Inhibitor Sales 2021-2026 (K Units)
Figure 34. Middle East & Africa Phosphodiesterase-4 Inhibitor Revenue 2021-2026 ($ millions)
Figure 35. Americas Phosphodiesterase-4 Inhibitor Sales Market Share by Country in 2026
Figure 36. Americas Phosphodiesterase-4 Inhibitor Revenue Market Share by Country (2021-2026)
Figure 37. Americas Phosphodiesterase-4 Inhibitor Sales Market Share by Type (2021-2026)
Figure 38. Americas Phosphodiesterase-4 Inhibitor Sales Market Share by Application (2021-2026)
Figure 39. United States Phosphodiesterase-4 Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Phosphodiesterase-4 Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Phosphodiesterase-4 Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Phosphodiesterase-4 Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Phosphodiesterase-4 Inhibitor Sales Market Share by Region in 2026
Figure 44. APAC Phosphodiesterase-4 Inhibitor Revenue Market Share by Region (2021-2026)
Figure 45. APAC Phosphodiesterase-4 Inhibitor Sales Market Share by Type (2021-2026)
Figure 46. APAC Phosphodiesterase-4 Inhibitor Sales Market Share by Application (2021-2026)
Figure 47. China Phosphodiesterase-4 Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Phosphodiesterase-4 Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Phosphodiesterase-4 Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Phosphodiesterase-4 Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 51. India Phosphodiesterase-4 Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Phosphodiesterase-4 Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Phosphodiesterase-4 Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Phosphodiesterase-4 Inhibitor Sales Market Share by Country in 2026
Figure 55. Europe Phosphodiesterase-4 Inhibitor Revenue Market Share by Country (2021-2026)
Figure 56. Europe Phosphodiesterase-4 Inhibitor Sales Market Share by Type (2021-2026)
Figure 57. Europe Phosphodiesterase-4 Inhibitor Sales Market Share by Application (2021-2026)
Figure 58. Germany Phosphodiesterase-4 Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 59. France Phosphodiesterase-4 Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Phosphodiesterase-4 Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Phosphodiesterase-4 Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Phosphodiesterase-4 Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Phosphodiesterase-4 Inhibitor Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Phosphodiesterase-4 Inhibitor Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Phosphodiesterase-4 Inhibitor Sales Market Share by Application (2021-2026)
Figure 66. Egypt Phosphodiesterase-4 Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Phosphodiesterase-4 Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Phosphodiesterase-4 Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Phosphodiesterase-4 Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Phosphodiesterase-4 Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Phosphodiesterase-4 Inhibitor in 2026
Figure 72. Manufacturing Process Analysis of Phosphodiesterase-4 Inhibitor
Figure 73. Industry Chain Structure of Phosphodiesterase-4 Inhibitor
Figure 74. Channels of Distribution
Figure 75. Global Phosphodiesterase-4 Inhibitor Sales Market Forecast by Region (2027-2032)
Figure 76. Global Phosphodiesterase-4 Inhibitor Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Phosphodiesterase-4 Inhibitor Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Phosphodiesterase-4 Inhibitor Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Phosphodiesterase-4 Inhibitor Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Phosphodiesterase-4 Inhibitor Revenue Market Share Forecast by Application (2027-2032)